Personal information

No personal information available

Activities

Collapse all

Employment (2)

University of Washington: Seattle, WA, US

(Obstetrics & Gynecology)
Employment
Source: Self-asserted source
Barbara Goff

Fred Hutchinson Cancer Research Center: Seattle, WA, US

Employment
Source: check_circle
Fred Hutchinson Cancer Center

Education and qualifications (1)

University of Pennsylvania School of Medicine: Philadelphia, Pennsylvania, US

M.D.
Education
Source: Self-asserted source
Barbara Goff

Works (50 of 153)

Items per page:
Page 1 of 4

Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access

JNCI: Journal of the National Cancer Institute
2024-12-19 | Journal article
DOI: 10.1093/jnci/djae338
Contributors: Ann Oluloro; Elizabeth M Swisher; Heidi J Gray; Barbara Goff; Kemi M Doll
Source: check_circle
Crossref

Since surgery isn't getting any easier, why is reimbursement going down? An update from the SGO taskforce on coding and reimbursement.

Gynecologic oncology
2016-12-11 | Journal article
DOI: 10.1016/j.ygyno.2016.06.008
PMID: 27287507
Source: Self-asserted source
Barbara Goff

The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN
2016-04-01 | Journal article
DOI: 10.6004/jnccn.2016.0049
PMID: 27059191
Source: Self-asserted source
Barbara Goff

An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.

Journal of minimally invasive gynecology
2016-01-08 | Journal article
DOI: 10.1016/j.jmig.2015.12.012
PMID: 26773577
Source: Self-asserted source
Barbara Goff

Ovarian cancer outcomes: Predictors of early death.

Gynecologic oncology
2015-12-29 | Journal article
DOI: 10.1016/j.ygyno.2015.12.021
PMID: 26743531
Source: Self-asserted source
Barbara Goff

Route of hysterectomy and surgical outcomes from a statewide gynecologic oncology population: is there a role for vaginal hysterectomy?

American journal of obstetrics and gynecology
2015-10-22 | Journal article
DOI: 10.1016/j.ajog.2015.10.006
PMID: 26470825
Source: Self-asserted source
Barbara Goff

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer.

Gynecologic oncology
2015-08-10 | Journal article
DOI: 10.1016/j.ygyno.2015.08.004
PMID: 26271155
PMC: PMC4993045
Source: Self-asserted source
Barbara Goff

Measuring ovarian cancer care: why are we still failing?

Gynecologic oncology
2015-01-01 | Journal article
DOI: 10.1016/j.ygyno.2014.12.008
PMID: 25554011
Source: Self-asserted source
Barbara Goff

An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.

Journal of Gynecologic Oncology
2014-11-06 | Journal article
DOI: 10.3802/jgo.2015.26.1.25
PMID: 25376917
PMC: PMC4302281
Source: Self-asserted source
Barbara Goff

SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm.

Gynecologic oncology
2014-08-12 | Journal article
DOI: 10.1016/j.ygyno.2014.08.004
PMID: 25124162
PMC: PMC4698962
Source: Self-asserted source
Barbara Goff

Physicians' beliefs about effectiveness of cancer screening tests: a national survey of family physicians, general internists, and obstetrician-gynecologists.

Preventive medicine
2014-07-17 | Journal article
DOI: 10.1016/j.ypmed.2014.07.009
PMID: 25038531
PMC: PMC4539137
Source: Self-asserted source
Barbara Goff

SGO not soft on morcellation: risks and benefits must be weighed.

The Lancet. Oncology
2014-04-01 | Journal article
DOI: 10.1016/s1470-2045(14)70075-0
PMID: 24694631
Source: Self-asserted source
Barbara Goff

Accuracy of ovarian and colon cancer risk assessments by U.S. physicians.

Journal of general internal medicine
2014-02-12 | Journal article
DOI: 10.1007/s11606-014-2768-2
PMID: 24519100
PMC: PMC4000350
Source: Self-asserted source
Barbara Goff

Independent radiologic review: bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer.

Gynecologic oncology
2014-02-06 | Journal article
DOI: 10.1016/j.ygyno.2014.02.003
PMID: 24508841
Source: Self-asserted source
Barbara Goff

Value of symptom-triggered diagnostic evaluation for ovarian cancer.

Obstetrics and gynecology
2014-01-01 | Journal article
DOI: 10.1097/AOG.0000000000000051
PMID: 24463666
PMC: PMC3904679
Source: Self-asserted source
Barbara Goff

Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey.

Journal of general internal medicine
2013-08-14 | Journal article
DOI: 10.1007/s11606-013-2567-1
PMID: 23943421
PMC: PMC3889955
Source: Self-asserted source
Barbara Goff

Ovarian cancer national alliance: a report of the 2012 Consensus Conference on Current Challenges in ovarian cancer.

Gynecologic oncology
2013-07-01 | Journal article
DOI: 10.1016/j.ygyno.2013.04.006
PMID: 23583417
Source: Self-asserted source
Barbara Goff

Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative.

Gynecologic oncology
2013-05-26 | Journal article
DOI: 10.1016/j.ygyno.2013.05.026
PMID: 23718934
Source: Self-asserted source
Barbara Goff

Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers.

Gynecologic oncology
2013-04-28 | Journal article
DOI: 10.1016/j.ygyno.2013.04.055
PMID: 23632207
PMC: PMC4527599
Source: Self-asserted source
Barbara Goff

Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.

Integrative Cancer Therapies
2013-04-26 | Journal article
DOI: 10.1177/1534735413485815
PMID: 23625025
PMC: PMC4613776
Source: Self-asserted source
Barbara Goff

An international assessment of ovarian cancer incidence and mortality.

Gynecologic oncology
2013-04-02 | Journal article
DOI: 10.1016/j.ygyno.2013.03.026
PMID: 23558050
Source: Self-asserted source
Barbara Goff

Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

Journal of Alternative and Complementary Medicine
2013-02-27 | Journal article
DOI: 10.1089/acm.2012.0295
PMID: 23445210
PMC: PMC3731675
Source: Self-asserted source
Barbara Goff

Advanced ovarian cancer: what should be the standard of care?

Journal of gynecologic oncology
2013-01-08 | Journal article
DOI: 10.3802/jgo.2013.24.1.83
PMID: 23346317
PMC: PMC3549512
Source: Self-asserted source
Barbara Goff

Nonrecommended breast and colorectal cancer screening for young women: a vignette-based survey.

American journal of preventive medicine
2012-09-01 | Journal article
DOI: 10.1016/j.amepre.2012.05.022
PMID: 22898115
Source: Self-asserted source
Barbara Goff

Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.

Translational Oncology
2012-08-01 | Journal article
DOI: 10.1593/tlo.12172
PMID: 22937176
PMC: PMC3431034
Source: Self-asserted source
Barbara Goff

Ovarian cancer: screening and early detection.

Obstetrics and gynecology clinics of North America
2012-06-01 | Journal article
DOI: 10.1016/j.ogc.2012.02.007
PMID: 22640710
Source: Self-asserted source
Barbara Goff

Evaluation of Society of Gynecologic Oncologists (SGO) ovarian cancer quality surgical measures.

Gynecologic oncology
2012-05-03 | Journal article
DOI: 10.1016/j.ygyno.2012.04.049
PMID: 22561039
Source: Self-asserted source
Barbara Goff

Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
2012-05-01 | Journal article
DOI: 10.1097/igc.0b013e318241d9b9
PMID: 22315094
Source: Self-asserted source
Barbara Goff

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2012-04-23 | Journal article
DOI: 10.1200/JCO.2012.42.0505
PMID: 22529265
PMC: PMC3646321
Source: Self-asserted source
Barbara Goff

Symptoms associated with ovarian cancer.

Clinical obstetrics and gynecology
2012-03-01 | Journal article
DOI: 10.1097/grf.0b013e3182480523
PMID: 22343227
Source: Self-asserted source
Barbara Goff

Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?

Annals of internal medicine
2012-02-01 | Journal article
DOI: 10.7326/0003-4819-156-3-201202070-00006
PMID: 22312138
Source: Self-asserted source
Barbara Goff

Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Gynecologic oncology
2011-11-06 | Journal article
DOI: 10.1016/j.ygyno.2011.10.032
PMID: 22063459
PMC: PMC3264692
Source: Self-asserted source
Barbara Goff

Involvement in decision-making about treatment and ovarian cancer survivor quality of life.

Gynecologic oncology
2011-10-29 | Journal article
DOI: 10.1016/j.ygyno.2011.10.029
PMID: 22044688
PMC: PMC4727540
Source: Self-asserted source
Barbara Goff

Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.

Obstetrics and gynecology
2011-10-01 | Journal article
DOI: 10.1097/aog.0b013e31822dabc6
PMID: 21934449
Source: Self-asserted source
Barbara Goff

Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer.

Gynecologic oncology
2011-09-26 | Journal article
DOI: 10.1016/j.ygyno.2011.08.030
PMID: 21945309
PMC: PMC3217095
Source: Self-asserted source
Barbara Goff

Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly.

Obstetrics and gynecology
2011-09-01 | Journal article
DOI: 10.1097/AOG.0b013e31822a6d56
PMID: 21860281
PMC: PMC3173498
Source: Self-asserted source
Barbara Goff

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.

Cancer
2011-07-25 | Journal article
DOI: 10.1002/cncr.26166
PMID: 21792861
Source: Self-asserted source
Barbara Goff

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.

American journal of obstetrics and gynecology
2011-06-01 | Journal article
DOI: 10.1016/j.ajog.2011.03.008
PMID: 21752752
Source: Self-asserted source
Barbara Goff

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.

Gynecologic oncology
2011-04-15 | Journal article
DOI: 10.1016/j.ygyno.2011.03.022
PMID: 21496889
PMC: PMC3104110
Source: Self-asserted source
Barbara Goff

Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.

Gynecologic oncology
2011-04-09 | Journal article
DOI: 10.1016/j.ygyno.2011.03.020
PMID: 21481441
PMC: PMC3138896
Source: Self-asserted source
Barbara Goff

How are symptoms of ovarian cancer managed? A study of primary care physicians.

Cancer
2011-03-16 | Journal article
DOI: 10.1002/cncr.26035
PMID: 21413001
Source: Self-asserted source
Barbara Goff

Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.

Cancer
2011-02-24 | Journal article
DOI: 10.1002/cncr.25967
PMID: 21815133
Source: Self-asserted source
Barbara Goff

Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer.

Gynecologic oncology
2011-02-15 | Journal article
DOI: 10.1016/j.ygyno.2010.11.049
PMID: 21324515
Source: Self-asserted source
Barbara Goff

FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.

Gynecologic oncology
2011-02-01 | Journal article
DOI: 10.1016/j.ygyno.2010.10.019
PMID: 21075432
Source: Self-asserted source
Barbara Goff

Pelvic exenteration in the age of modern chemoradiation.

Gynecologic oncology
2011-01-21 | Journal article
DOI: 10.1016/j.ygyno.2010.11.044
PMID: 21256580
Source: Self-asserted source
Barbara Goff

Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.

Neoplasia (New York, N.Y.)
2010-12-01 | Journal article
DOI: 10.1593/neo.101044
PMID: 21170264
PMC: PMC3003134
Source: Self-asserted source
Barbara Goff

Training and assessment in gynaecologic surgery: the role of simulation.

Best practice & research. Clinical obstetrics & gynaecology
2010-12-01 | Journal article
DOI: 10.1016/j.bpobgyn.2010.03.006
PMID: 20605529
Source: Self-asserted source
Barbara Goff

The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.

Cancer
2010-11-01 | Journal article
DOI: 10.1002/cncr.25439
PMID: 20665887
PMC: PMC2975783
Source: Self-asserted source
Barbara Goff

MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.

Genes, chromosomes & cancer
2010-07-01 | Journal article
DOI: 10.1002/gcc.20768
PMID: 20461750
PMC: PMC2869465
Source: Self-asserted source
Barbara Goff

The abandoned radical hysterectomy for cervical cancer: clinical predictors and outcomes.

Obstetrics and gynecology international
2010-04-28 | Journal article
DOI: 10.1155/2010/743794
PMID: 20454444
PMC: PMC2861195
Source: Self-asserted source
Barbara Goff
Items per page:
Page 1 of 4

Peer review (2 reviews for 1 publication/grant)

Review activity for Gynecologic oncology. (2)
How many people are using ORCID?